ACE2 and infection: Other human coronaviruses that utilize ACE2 for binding and entry may be suitable as surrogate platforms for the study of SARS-CoV-2 in vitro, so long as they can be propagated in the laboratory and are able to elicit cellular infection phenotypes that can be quantitatively measured.